Navigation Links
Leading Immunologists Convene in Boston
Date:6/2/2008

Annual meeting of the Federation of Clinical Immunology Societies opens June 5

BOSTON, June 2 /PRNewswire-USNewswire/ -- Over a thousand scientists and clinicians will convene to present new advances in understanding and treating immune-mediated diseases at FOCIS 2008, the 8th annual meeting of the Federation of Clinical Immunology Societies (FOCIS), June 5-9 at the Boston Marriott Copley Place.

Conference participants will present new research findings for conditions in which the human immune system plays a significant role, such as Multiple Sclerosis, cancer, allergy and asthma, diabetes, inflammatory bowel disease, and AIDS. The topics and speakers will address underlying immune pathogenesis, novel therapies and shared insights on topics such as new mechanisms and therapeutic targets, innovations in genetic approaches and how inflammatory regulators communicate danger.

In contrast to traditional medical meetings which focus on particular medical specialties, the FOCIS approach is to highlight and probe the underlying common elements of diseases which can lead to better therapies. "As the immunology field rapidly advances in clinical trials and the introduction of new and specific immunotherapies the opportunity to share knowledge and speed progress has never been greater," says Dr. Jerry Nepom, MD, PhD, Director of the Benaroya Research Institute at Virginia Mason, Seattle, Wash. and president of FOCIS.

"Today, immunology represents a critical pathway to unlock answers to treat many of today's diseases. To that end, it is important to broaden the access to educational programs to further immunological knowledge for investigators, basic scientists and clinicians. The FOCIS annual meeting provides a forum for this timely exchange. This meeting brings special value by translating knowledge from basic science into multiple clinical disciplines to both understand and treat immune-based diseases," Nepom said.

Nepom says the translational approach to medicine is taking hold at medical schools and hospitals around the country. For instance, the National Institutes of Health, the US government's medical research body, launched its Roadmap for Medical Research to establish a call for scientists to move beyond the confines of their own discipline and explore new organizational models for team science.

"Translational medicine is the future, as we know it," Nepom said. "FOCIS has been the voice of translational immunology and we're very excited that this idea beginning to change the way we view medicine."

For more information about FOCIS 2008 and program scheduling, visit HYPERLINK "http://www.focisnet.org/" http://www.focisnet.org.


'/>"/>
SOURCE Federation of Clinical Immunology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
2. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
3. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
4. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
5. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
6. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
9. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
10. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
11. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... 2016  The National Pharmaceutical Council (NPC) today ... policy research organization as its newest member.  ... vice president and chief scientific officer, Mallinckrodt Pharmaceuticals, ... NPC Board of Directors. ... joined us in support of our efforts to ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):